STAT

OCTOBER 18, 2023

But at the STAT Summit on Wednesday, Daniel Skovronsky, the chief scientific and medical officer at Eli Lilly, discussed how Lilly has been able to crack both obesity and Alzheimer’s , two areas that have long stumped drug developers, and now two of the hottest commercial opportunities.

Drug Development 266

Drug Development 266

PharmaVoice

JANUARY 10, 2024

Although AI’s failure rates in drug development still leave room for improvement, today’s missteps feed tomorrow’s successes.

Drug Development 147

Drug Development 147

STAT

MARCH 15, 2023

STAT’s Matthew Herper struck an industry nerve when he wrote that the drug development industry is “not prepared for the next wave of biotech innovation.” ” His report ends on a somewhat dismal note: the industry is long on diagnosis (clinical development is too expensive) and short on cures.

Drug Development 234

Drug Development 234

PharmaVoice

OCTOBER 26, 2022

The Stanford researcher and biotech entrepreneur discusses how click and bioorthogonal chemistry could revolutionize drug development.

Drug Development 264

Drug Development 264

STAT

AUGUST 7, 2023

A behind-the-scenes feud over a drug development program erupted into public view as Nektar Therapeutics filed a lawsuit accusing Eli Lilly of undermining a project in favor of another deal.

Drug Development 207

Drug Development Drug Pricing 207

European Pharmaceutical Review

JANUARY 11, 2024

Quotient Sciences leverage more than 30 years of drug development expertise to support small molecule and synthetic peptide drug programmes, in both simple drug programmes as well as complex cases where specialised formulation expertise and technologies are required.

Drug Development 111

Drug Development 111

pharmaphorum

JULY 17, 2024

Discover how artificial intelligence is revolutionising drug development and compliance in the pharmaceutical industry with these four impactful ways.

Drug Development 64

Drug Development 64

Outsourcing Pharma

APRIL 3, 2024

Precision oncology innovator SimBioSys and General Inception have joined forces in a strategic partnership aimed at revolutionizing cancer drug development.

Drug Development 97

Drug Development 97

Pharmaceutical Technology

JULY 17, 2024

As US China trade relations are set to be impacted by the BIOSECURE Act, pharma companies exploring CDMOs outside China may need to contend with increased drug development and manufacturing costs.

Drug Development 59

Drug Development 59

pharmaphorum

MARCH 19, 2024

Learn how AI and enhanced medical affairs roles are transforming the landscape of drug development and patient engagement in the health industry. Explore the benefits and advancements in this exciting field.

Drug Development 121

Drug Development 121

Pharmaceutical Commerce

JULY 22, 2024

Analyzing the divergent paths undertaken by small biotech and large pharma companies in drug development.

Drug Development 52

Drug Development 52

European Pharmaceutical Review

JANUARY 2, 2024

Over the past several years, the pharmaceutical industry has faced challenges regarding quality assurance in drug development, the author asserted. It also lowers the regulatory burden too, the paper reported. [In

Drug Development 105

Drug Development Biosimilars Documentation 105

STAT

FEBRUARY 13, 2024

The assault on the development of new lifesaving therapies continues apace. Recently, the First Appellate Division of California Appeals held that companies not only have to defend products they have developed and marketed, but also those they have not.

Drug Development 299

Drug Development 299

pharmaphorum

JUNE 15, 2022

The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine. Improve your drug development rationale across all lines of NSCLC and address challenges when moving therapies forward. Progress sequencing and combination approaches.

Drug Development 105

Drug Development Immunity Immunization 105

Outsourcing Pharma

JUNE 19, 2024

During a panel discussion held at DIA Global in San Diego this week, which was moderated by Peter Wahl, industry experts delved into the integration of real-world (RW) data and advanced technologies to accelerate drug development.

Drug Development 94

Drug Development 94

Pharmaceutical Technology

JUNE 20, 2024

Researchers at the University of Birmingham have discovered a mechanism of enzyme communication that could aid drug development.

Drug Development 52

Drug Development Communication 52

PharmaVoice

JANUARY 12, 2023

Merck, Bristol Myers Squibb and others are taking small R&D steps in space that could lead to giant leaps for patients.

Drug Development 264

Drug Development 264

PharmaVoice

AUGUST 23, 2022

PsychoGenics is leveraging AI-driven drug discovery platforms to advance mental health treatments for schizophrenia, bipolar disorder and treatment-resistant depression.

Drug Development 263

Drug Development 263

BioPharma Dive

NOVEMBER 13, 2023

How can these increase the probability of success or efficiency in a pre-clinical and clinical drug development program? Regulatory agencies have set the framework and use cases for RWE.

Drug Development 107

Drug Development 107

European Pharmaceutical Review

SEPTEMBER 12, 2023

Initial data from the CPHI Annual Report 2023, which provides insight from 250 global pharmaceutical companies, reveals that AI (artificial intelligence) is expected to transform every area of the industry, from drug discovery through to drug development , within the next 24-months. Attending CPHI Barcelona 2023?

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

PharmaTech

APRIL 23, 2024

Lonza Small Molecules is focused on leveraging its technologies and expertise to address solubility challenges and support drug development programs through commercialization.

Drug Development 52

Drug Development 52

Pharmaceutical Technology

MAY 22, 2024

Sanofi has entered a collaboration with Formation Bio and OpenAI aimed at harnessing AI to expedite drug development.

Drug Development 59

Drug Development 59

European Pharmaceutical Review

FEBRUARY 22, 2023

Small companies will need to either defer development or find a partner willing to fund the confirmatory Phase III programme. 5 Psychedelic research: evaluating the fast-evolving regulatory roadmap Experience of accelerated drug development The other impediment to accelerated development is an increased focus on “long-term patient outcomes”.

Drug Development 97

Drug Development 97

European Pharmaceutical Review

DECEMBER 1, 2023

During CPHI Barcelona, EPR Editor Caroline Peachey asked Anil Kane, Global Head of Technical & Scientific Affairs, Pharma Services, at Thermo Fisher Scientific about the dynamic landscape of pharmaceutical drug development. What are the trends affecting drug development today?

Drug Development 98

Drug Development Dosage Diabetes Process Improvement 98

European Pharmaceutical Review

MAY 11, 2023

The US Food and Drug Administration (FDA) has released a discussion paper to complement and inform future guidance on artificial intelligence (AI) and machine learning (ML) in drug development. The post FDA publishes paper on AI/ML in drug development appeared first on European Pharmaceutical Review.

Drug Development 104

Drug Development Pharmaceutical Manufacturing Communication 104

European Pharmaceutical Review

JUNE 27, 2022

Pursuing new paths in targeted protein degradation drug development. The post Drug Development In-Depth Focus 2022 appeared first on European Pharmaceutical Review. Targeted protein degradation (TPD) therapy has grown rapidly as a field, with transformational potential.

Drug Development 105

Drug Development 105

pharmaphorum

APRIL 25, 2024

9th Microbiome Movement Drug Development Summit Mike.Hammerton Thu, 25/04/2024 - 09:09 Bookmark this

Drug Development 52

Drug Development 52

Pharmaceutical Business Review

APRIL 24, 2024

This model allows pharma companies to manage clinical plans, drug development strategies, and resource allocation centrally, while its subsidiaries can ensure focus ing on the advancement of new drug assets and other technological innovations. Besides, t he scalability and resource efficiency of the model are particularly beneficial as clinical (..)

Drug Development 59

Drug Development 59

PharmaVoice

DECEMBER 12, 2022

Learn why an informed, holistic view is needed to succeed in today’s complex and dynamic landscape.

Drug Development 246

Drug Development 246

PharmExec

APRIL 2, 2024

In this Pharmaceutical Executive video interview, Optum Rx clinical pharmacist, Arash Sadeghi, discusses upcoming advancements in the drug pipeline and trends shaping the future of drug development.

Drug Development 52

Drug Development 52

STAT

MARCH 31, 2023

Academia can be an excellent source of novel drug targets and new technologies that can enhance medicinal discovery. Indeed, academic inventors or founders contributed to more than one-quarter of all medicines approved from 2001 through 2019. Yet many sponsored research collaborations that hope to tap into academia fail.

Drug Development 255

Drug Development 255

PharmaVoice

JANUARY 9, 2023

How the IRLAB Therapeutics CEO is guiding the company in its development of potentially groundbreaking Parkinson’s disease treatments.

Drug Development 246

Drug Development 246

Express Pharma

APRIL 11, 2023

should be completed before a new drug development is started. The post Generic drug development: The way forward appeared first on Express Pharma. Assign a sequential queue number to projects based on priority to ensure the right set of projects is given attention by all concerned.

Drug Development 93

Drug Development Generic Medicine Documentation 93

Outsourcing Pharma

APRIL 8, 2024

In an exclusive interview with Dr Vanessa Zann, (pictured below) executive drug development consultant at Quotient Sciences, OSP delved into the forefront of pharmaceutical research and development.

Drug Development 62

Drug Development 62

pharmaphorum

NOVEMBER 22, 2021

The 2nd annual Mitochondria-Targeted Drug Development Summit returns as the only industry-led meeting focused on overcoming the challenge of treating unmet medical needs caused by mitochondrial dysfunction. The post 2nd Mitochondria-Targeted Drug Development Summit appeared first on.

Drug Development 98

Drug Development 98

PharmaTech

AUGUST 2, 2023

An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.

Drug Development 52

Drug Development 52

PharmaTech

MARCH 25, 2024

In this episode of the Drug Solutions Podcast, Jan Bekkar, director of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Drug Development 52

Drug Development 52